Increase in Shares and Share Capital Through Exercise of Stock Acquisition Rights
First written in FY2017-Q2. 21 of 22 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2026-H1.
102 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「19 March 2026 (Note) 27,200 80,905,100 49 8,233 49 8,266」
Restricted stock compensation increased the total number of shares outstanding by 27,200 shares and increased both stated capital and the capital reserve by ¥49 million. - FY2022AdvancedAnnual report
「The 598,400-share increase in common shares outstanding resulted from a 559,200-share increase through the exercise of stock acquisition rights (stock options) and a 39,200-share increase through restricted stock compensation.」
The exercise of stock acquisition rights and other factors increased shares outstanding by 598,400, and also increased stated capital and the capital reserve. - FY2022-Q3AdvancedAnnual report
「1 June 2022–31 August 2022 (Note 1) 136,200 80,684,200 6 8,033 6 8,066」
The exercise of stock acquisition rights increased the total number of shares outstanding by 136,200 shares in the third quarter, and increased both stated capital and the capital reserve by ¥6 million. - FY2022-Q2AdvancedAnnual report
「1 March 2022–18 March 2022 (Note 1) 36,000 80,396,600 1 7,972 1 8,005 18 March 2022 (Note 2) 39,200 80,435,800 49 8,021 49 8,054 19 March 2022–31 May 2022 (Note 1) 112,200 80,548,000 5 8,027 5 8,060」
The exercise of stock acquisition rights increased the number of shares by a total of 148,200 during the second quarter, and also increased capital stock and capital surplus. Separately, 39,200 shares were issued as restricted stock-based compensation. - FY2022-Q1AdvancedAnnual report
「1 December 2021–28 February 2022 (Note) 223,800 80,360,600 8 7,970 8 8,003」
The exercise of stock acquisition rights increased the total number of issued shares by 223,800, while capital stock and capital surplus each increased by ¥8 million. - FY2021AdvancedAnnual report
「The increase of 2,776,800 issued common shares resulted from an increase of 1,350,000 shares through the exercise of stock acquisition rights attached to bonds with stock acquisition rights subject to revised exercise price provisions, etc., 1,382,400 shares through the exercise of stock acquisition rights (stock options), and 44,400 shares through restricted stock-based compensation based on a resolution of the annual general meeting of shareholders.」
The exercise of stock acquisition rights and other transactions increased the number of issued shares by 2,776,800, while capital stock and capital surplus each increased by ¥1,036 million. - FY2021-Q3AdvancedAnnual report
「1 June 2021–31 August 2021 (Note) 99,600 80,038,400 4 7,957 4 7,990」
The exercise of stock acquisition rights during the third quarter increased the total number of issued shares by 99,600, while capital stock and capital surplus each increased by ¥4 million. - FY2021-Q2AdvancedAnnual report
「1 March 2021–31 May 2021 (Note) 1,071,600 79,938,800 86 7,953 86 7,986」
The exercise of stock acquisition rights increased the total number of issued shares by 1,071,600, while capital stock and capital surplus each increased by ¥86 million. - FY2021-Q1AdvancedAnnual report
「Number of bonds with stock acquisition rights subject to revised exercise price provisions, etc., exercised during the quarterly accounting period (units) 13,500 Number of shares delivered upon exercise during the quarterly accounting period (shares) 1,350,000 Funds raised through exercises during the quarterly accounting period (¥ million) 1,866」
During the quarter, 13,500 stock acquisition rights were exercised, 1,350,000 shares were delivered, and ¥1,866 million was raised. - FY2020-Q3AdvancedAnnual report
「1 June 2020–31 August 2020 (Note) 112,200 75,883,600 5 6,116 5 6,149」
During the third quarter, the exercise of stock acquisition rights increased the number of issued shares by 112,200, while capital stock and capital surplus each increased by ¥5 million. - FY2020-Q2AdvancedAnnual report
「1 March 2020–31 May 2020 (Note) 280,800 75,771,400 13 6,111 13 6,144」
The exercise of stock acquisition rights increased the number of issued shares by 280,800, while capital stock and capital surplus each increased by ¥13 million. - FY2020-Q1AdvancedAnnual report
「1 December 2019–29 February 2020 (Note) 62,400 75,490,600 2 6,098 2 6,131」
The exercise of stock acquisition rights increased the total number of issued shares by 62,400, while capital stock and capital surplus each increased by ¥2 million. - FY2019AdvancedAnnual report
「1 December 2018–30 November 2019 (Note 1) 5,800,000 75,428,200 2,950 6,095 2,950 6,128」
The exercise of stock acquisition rights and other transactions increased the number of issued shares by 5,800,000, while capital stock and capital surplus each increased by ¥2,950 million. - FY2019-Q3AdvancedAnnual report
「1 June 2019–31 August 2019 79,200 75,302,800 2 6,089 2 6,122」
During the third quarter, the exercise of stock acquisition rights increased the number of issued shares by 79,200, while capital stock and capital surplus each increased by ¥2 million. - FY2019-Q1AdvancedAnnual report
「Number of bonds with stock acquisition rights subject to revised exercise price provisions, etc., exercised during the quarterly accounting period (units) 3,500 Number of shares delivered upon exercise during the quarterly accounting period (shares) 350,000 Funds raised through exercises during the quarterly accounting period (¥ million) 332」
A total of 3,500 stock acquisition rights subject to revised exercise price provisions were exercised, 350,000 shares were delivered, and ¥332 million was raised. - FY2018AdvancedAnnual report
「1 December 2017–30 November 2018 (Note 1) 1,657,800 69,628,200 75 3,144 75 3,177」
The exercise of stock acquisition rights increased the number of issued shares by 1,657,800 during the fiscal year, while capital stock and capital surplus each increased by ¥75 million. - FY2018-Q3AdvancedAnnual report
「1 June 2018–31 August 2018 (Note 1) 321,600 69,373,200 15 3,132 15 3,165」
The exercise of stock acquisition rights increased the total number of issued shares by 321,600, while capital stock and capital surplus each increased by ¥15 million. - FY2018-Q2AdvancedAnnual report
「1 March 2018–31 May 2018 (Note 1) 957,000 69,051,600 43 3,117 43 3,150」
During the second quarter, the exercise of stock acquisition rights increased the total number of issued shares by 957,000, while capital stock and capital surplus each increased by ¥43 million. - FY2018-Q1AdvancedAnnual report
「1 December 2017–28 February 2018 (Note 2) 124,200 68,094,600 5 3,074 4 3,106」
During the first quarter, the exercise of stock acquisition rights increased the total number of issued shares by 124,200, while capital stock increased by ¥5 million and capital surplus increased by ¥4 million. - FY2017AdvancedAnnual report
「The increase of 12,365,300 issued common shares resulted from an increase of 10,342,700 shares through the stock split, 1,503,000 shares issued through a public offering, 390,000 shares through a third-party allotment, and 129,600 shares through the exercise of stock acquisition rights (stock options).」
The exercise of stock acquisition rights increased the number of issued shares by 129,600, and also increased capital stock and capital surplus. - FY2017-Q3AdvancedAnnual report
「1 June 2017–31 August 2017 (Note 1) 25,000 20,734,800 2,614 720,951 2,571 753,756」
During the third quarter, the total number of issued shares increased by 25,000 through the exercise of stock acquisition rights, while capital stock increased by ¥2.614 million and capital surplus increased by ¥2.571 million. - FY2017-Q2First statedAnnual report
「1 March 2017–31 May 2017 (Note 1) 123,200 20,709,800 9,974 718,336 9,822 751,184」
The total number of issued shares increased by 123,200 shares during the quarter through the exercise of stock acquisition rights, while capital stock increased by ¥9.974 million and capital surplus increased by ¥9.822 million.